| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/13/2008 | CN101120776A Method for extracting beta-glucan from cereal bran using membrane separation technology |
| 02/13/2008 | CN100368421C Method for picking up and separating compound of flavone being as effective content of cinquefoil, and application |
| 02/13/2008 | CN100368420C Novel aromatic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 02/13/2008 | CN100368411C 7-azaindoles as inhibitors of c-Jun N-terminal kinases for the treatment of neurodegenerative disorders |
| 02/13/2008 | CN100368407C 2-aminobenzothiazoles as CB1 receptor inverse agonists |
| 02/13/2008 | CN100368398C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
| 02/13/2008 | CN100368397C Prodrugs to d-prolines |
| 02/13/2008 | CN100368386C Process for synthesizing (+/-)p-fluoro-2(2-methyl-propionyl)-4-oxy-N,3-diphenyl-phenylbutylamide |
| 02/13/2008 | CN100368381C Tetra-(alpha-amino-acid or dipeptide) complexes of di-copper and synthetic method, and SOD loke activity |
| 02/13/2008 | CN100368374C Carboxylic compound and medicine comprising the same |
| 02/13/2008 | CN100367960C Process for producing coated preparation |
| 02/13/2008 | CN100367947C Pharmaceutical composition containing fenofibrate with high efficacy for hyperlipemia, its preparation method and use |
| 02/12/2008 | US7329782 Compounds for the treatment of metabolic disorders |
| 02/12/2008 | US7329754 modulators of the monoamine receptors, in particular the serotonin, dopamine and norepinephrine receptors, and the biogenic amine transporters for serotonin, dopamine and norepinephrine; |
| 02/12/2008 | US7329731 Soluble T cell receptor |
| 02/12/2008 | US7329729 Secreted epithelial colon stromal-1 molecules and uses thereof |
| 02/12/2008 | US7329686 Specific inhibitors of one or more isoforms of nitric oxide synthase; 3-[[2-amino-1-phenylethyl]thio]-5-methyl-2-thiophenecarbonitrile; antiinflammatory agent; pain |
| 02/12/2008 | US7329684 Modulators of the receptor for advanced glycated end products and interact with its ligands; antiinflammatory, antidiabetic and antitumor agents; Alzheimer's disease, erectile dysfunction, metastasis; 2-[(1R)-2-(4-Benzyloxyphenyl)-1-amino-1-ethyl]-3-butyl-5-(3-diethylamino-1-propoxy)benzimidazole |
| 02/12/2008 | US7329683 Moderation of cortisol; non-insulin dependent diabetes; hypotensive agents; using a 1,2,4 triazole compound |
| 02/12/2008 | US7329680 Heterocycle substituted carboxylic acids |
| 02/12/2008 | US7329660 Phthalazine derivatives for treating inflammatory diseases |
| 02/12/2008 | US7329658 Cannabinoid receptor ligands and uses thereof |
| 02/12/2008 | US7329657 Indazolyl-substituted pyrroline compounds as kinase inhibitors |
| 02/12/2008 | US7329651 Cannabimimetic ligands |
| 02/12/2008 | US7329646 recombinant methods; |
| 02/12/2008 | US7329511 Nucleic acid encoding GAD65 |
| 02/12/2008 | CA2496623C Benzenesulfonate salts of 4-fluoro-2-cyanopyrrolidine derivatives |
| 02/12/2008 | CA2374003C Improved cellular uptake of bioactive agents |
| 02/12/2008 | CA2373473C Electrolyte gels for maintaining hydration and rehydration |
| 02/12/2008 | CA2321122C E-2-[4-(4-chloro-1,2-diphenyl-but-1-enyl)phenoxy]ethanol and pharmaceutical compositions thereof |
| 02/12/2008 | CA2303432C Modulation of drug loading in multivesicular liposomes |
| 02/12/2008 | CA2294582C Treatment of diabetes with thiazolidinedione and metformin |
| 02/12/2008 | CA2267543C Use of sulodexide and of the medicines containing it in the treatment of the diabetic retinopathy |
| 02/12/2008 | CA2202137C Composition, device and method for enhanced electrotransport agent delivery |
| 02/12/2008 | CA2163196C Regulation of antigen presentation |
| 02/07/2008 | WO2008016883A2 Inhibitors of plasma kallikrein |
| 02/07/2008 | WO2008016314A1 Myostatin antagonists |
| 02/07/2008 | WO2008016282A1 Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase d and rheb |
| 02/07/2008 | WO2008016281A1 Method of regulating mammalian target-of-rapamycin activity by interaction between phospholipase d and raptor |
| 02/07/2008 | WO2008016175A1 Activator for peroxisome proliferator activated receptor |
| 02/07/2008 | WO2008016132A1 Benzyl phenyl glucopyranoside derivative |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016118A1 Agent targeting dopamine receptor and screening method therefor |
| 02/07/2008 | WO2008016107A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 02/07/2008 | WO2008015950A1 Acat inhibitor |
| 02/07/2008 | WO2008015867A1 Method for activating and stabilizing dissolved hydrogen in water |
| 02/07/2008 | WO2008015850A1 Composition for prevention and amelioration of metabolic syndrome |
| 02/07/2008 | WO2008015763A1 Drug formulation containing fibrate medicament and process for producing the same |
| 02/07/2008 | WO2008015563A2 Salts of rosuvastatin and processes for their preparation |
| 02/07/2008 | WO2008015335A1 N-(aminoheteroaryl)-1h-indole-2-carboxamide derivatives, and preparation and therapeutic application thereof |
| 02/07/2008 | WO2008015275A1 Fractions of whey permeate and its use for the prevention and therapy of type 2 diabetes and the metabolic syndrome |
| 02/07/2008 | WO2008015125A1 1h-indol-6-yl-piperazin-1-yl-methanone-derivatives for use as h3 receptor modulators |
| 02/07/2008 | WO2008015081A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
| 02/07/2008 | WO2007146758A3 Novel mch receptor antagonists |
| 02/07/2008 | WO2007124734A3 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/07/2008 | WO2007113683A3 Modulation of tc10 function and method of treating glucose metabolic disorders |
| 02/07/2008 | WO2007111806A3 Cyclopentane heptanoic acid compounds for reducing body fat |
| 02/07/2008 | WO2007098500A3 A method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent |
| 02/07/2008 | WO2007070506B1 Diaza heterocyclic sulfonamide derivatives and their uses |
| 02/07/2008 | WO2006044063A3 Transepithelial delivery of peptides with incretin hormone activities |
| 02/07/2008 | US20080033204 Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl) amino] butanoate |
| 02/07/2008 | US20080033170 Novel compounds |
| 02/07/2008 | US20080033165 2-(3-(2-phenyloxazolidin-4-on-3-yl)-4-(2-styryl)-azetidin-2-on-1-yl) alkanedioic acid derivatives and corresponding alkoxyalkanoic acid derivatives; treating psychological disorders, cardiovascular disorders |
| 02/07/2008 | US20080033042 Urea-and urethane-substituted acylureas, process for their preparation and their use |
| 02/07/2008 | US20080033040 Methods And Compositions For Screening Involving Endothelial Cells Under Shearing Conditions |
| 02/07/2008 | US20080033032 Novel Polymorphs Of The Potassium Salt Of Atorvastatin |
| 02/07/2008 | US20080033030 Fluvastatin sodium pharmaceutical compositions |
| 02/07/2008 | US20080033012 Enzyme inhibitors |
| 02/07/2008 | US20080032998 Pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/07/2008 | US20080032996 Substituted Quinazoline or Pyridopyrimidine Derivative |
| 02/07/2008 | US20080032993 Substituted heterocyclic compounds |
| 02/07/2008 | US20080032987 Quercetin-containing compositions |
| 02/07/2008 | US20080032984 1-Ethyl-6-methyl-3-phenyl-1H-pyrinido[5,4-e]1,2,4]triazine-5,7-dione, used for lowering blood sugar, treating non-insulin dependent diabetes and insulin resistance; antidiabetic agents |
| 02/07/2008 | US20080032983 Ortho-Substituted N'-Benzylidene-(3-Hydroxyphenyl)Acethydrazides |
| 02/07/2008 | US20080032982 2-{2-[3-(4-chlorophenyl)acryloyl]-4-methylphenoxy}-4-phenylbutanoic acid; Peroxisome Proliferator Activated Receptors (PPAR); diabetes, dyslipidemia and/or atherosclerosis |
| 02/07/2008 | US20080032981 Aryl n-cyanoguanidines and methods related thereto |
| 02/07/2008 | US20080032978 Soluble epoxide hydrolase inhibitors |
| 02/07/2008 | US20080032976 Histamine 3 receptor antagonists and/or inverse agonists; for obesity, metabolic syndrome (syndrome X), and other eating disorders; (4-cyclopentyl-piperazin-1-yl)-[3-(1-isopropyl-piperidin -4-yl)-l H-indol-6-yl]-methanone |
| 02/07/2008 | US20080032973 2-Quinazolinone compounds and methods of use |
| 02/07/2008 | US20080032971 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 02/07/2008 | US20080032969 Novel compounds |
| 02/07/2008 | US20080032968 New compounds |
| 02/07/2008 | US20080032964 Process for the synthesis of azetidinone |
| 02/07/2008 | US20080032961 Therapy employing LXRalpha modolators |
| 02/07/2008 | US20080032956 2-Ethyl and 2-Ethylidene-19-Nor-Vitamin D Compounds |
| 02/07/2008 | US20080032952 Combination Therapies Employing Nicotinic Acid Derivatives or Fibric Acid Derivatives |
| 02/07/2008 | US20080032915 Cysteine Rich Peptides for Improving Thiol Homeostasis |
| 02/07/2008 | US20080031966 Sustained release compositions for delivery of pharmaceutical proteins |
| 02/07/2008 | US20080031964 Combination therapeutic compositions and method of use |
| 02/07/2008 | US20080031957 Pulmonary delivery of 1alpha,25-dihydroxyvitamin D3 and co-administration of parathyroid hormone or calcitonin |
| 02/07/2008 | US20080031925 Compositions and Methods to Lower Glycohemoglobin Levels |
| 02/07/2008 | US20080031904 Combination consisting of a magnesium preparation having a prolonged release and of another active substance, and use thereof in the fields of cosmetics, therapeutics and/or nutrition |
| 02/07/2008 | US20080031880 Use of ErbB receptor ligands in treating diabetes |
| 02/07/2008 | US20080031875 Treatment method |
| 02/07/2008 | US20080031864 PEG-Urate Oxidase Conjugates and Use Thereof |
| 02/07/2008 | US20080031863 Method of Preparation and Use of Fibrinolytic Enzymes in the Treatment of Disease |
| 02/07/2008 | US20080031826 Devices containing lipid emulsions |
| 02/07/2008 | US20080031825 Pharmaceutical Compositions Comprising Effervescent Agents And Fenofibrate |
| 02/07/2008 | DE102006036285A1 Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms Fractions of whey permeate and their use for the prevention and treatment of type 2 diabetes and the metabolic syndrome |
| 02/07/2008 | CA2693378A1 Myostatin antagonists |